Skip to product information
1 of 2

AC-262536 Solution, 300mg (10mg/mL)

AC-262536 Solution, 300mg (10mg/mL)

Regular price €49,99
Regular price Sale price €49,99
Sale Sold out
Tax included. Shipping calculated at checkout.


AC-262 is a drug developed by Acadia Pharmaceuticals that acts as a selective androgen receptor modulator (SARM). Chemically, it exhibits endo-exo isomerism, with the endo form being the biologically active one.

It serves as a partial agonist for the androgen receptor with a binding affinity (Ki) of 5 nM. Additionally, it shows no significant affinity for other receptors that have been tested.

In animal studies, AC-262536 demonstrated a maximum anabolic effect that is approximately 66% of the anabolic activity of testosterone, and only about 27% of testosterone's androgenic potency.


This material is sold for use in laboratory research only. Terms of sale apply. Not for human consumption, nor for medical, veterinary or domestic use. Please familiarize yourself with our DISCLAIMER before ordering.

Included is a precision pipette marked per 0.2 ml!

Data sheet

AC-262536 – Solution, 300mg (10mg/mL)

Application SARM, AR partial agonist
CAS 870888-46-3
Molar Mass 278.348 g/mol
Chemical Formula C18H18N2O
IUPAC Name 4-(3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)naphthalene-1-carbonitrile
Synonyms AC-262,536, AC-262536, CHEMBL468938, SCHEMBL4879629
Storage Room temperature
Solubility Soluble in DMSO
Organoleptic Profile Clear Liquid
Physical Form Solution in DMSO, PEG400
Specification 10mg/mL ±5%
Terms This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.


View full details